Assessment of [Ca2+]m uptake (Figure 5B and Supplementary Figure 1B), migration and invasion (Figure 5C and Supplementary Figure 1C), glucose uptake, ATP levels, LDH levels, and lactate production (Figure 5D-5G and Supplementary Figure 1D) confirmed that miR-340 directly targets MCU to inhibit both cancer cell migration and invasion and glycolysis. The gene discussed is MCU; the disease is cancer.